Agranulocytosis secondary to cancer chemotherapy D70.1

  • D70.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2019 edition of ICD-10-CM D70.1 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of D70.1 - other international versions of ICD-10 D70.1 may differ.
Code Also:
  • underlying neoplasm
Use Additional:
  • code for adverse effect, if applicable, to identify drug (T45.1X5)

Codes: = Billable

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.